Global demand for Amino Acid Metabolism Disorders Treatment Market was valued at approximately USD 697.67 Million in 2018, and is expected to generate revenue of around USD 1075.51 Million by end of 2025, growing at a CAGR of around 6.46% between 2018 and 2025.
The report covers forecast and analysis for the Amino Acid Metabolism Disorders Treatment market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Amino Acid Metabolism Disorders Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Amino Acid Metabolism Disorders Treatment market on a global level. In order to give the users of this report a comprehensive view on the Amino Acid Metabolism Disorders Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein indication, product, distribution channel, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
According to the report, global demand for Amino Acid Metabolism Disorders Treatment Market was valued at approximately USD 697.67 Million in 2018, and is expected to generate revenue of around USD 1075.51 Million by end of 2025, growing at a CAGR of around 6.46% between 2018 and 2025.
Amino acid is the building block that allows one's body to produce proteins. Hydrogen (H), nitrogen (N), oxygen (O), and carbon (C) and others are the components present in amino acid. Nearly 500 naturally occurring amino acids have been identified, only 20 of which are evident in the genetic code, which can be further divided into innumerable ways. At least one amino acid-related metabolic disease. Metabolic diseases may occur when unusual chemical reactions take over the normal metabolic process. Moreover, the case may be that the amino acid gets into the cells. Therefore, the production of toxic material in the body is responsible for these problems.
The study provides a decisive view on the Amino Acid Metabolism Disorders Treatment market by segmenting the market based on Enzyme, Indication, Product, Distribution Channel and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Indication, the market is segmented into Argininosuccinic academia, Citrullinemia, Homocystinuria, Phenylketonuria and Maple syrup urine disease. Among these, by the end of the forecast period, phenylketonuria is predicted to emerge dominant.
Based on the Product segment, the market is bifurcated into Arginine, Betaine, Carglumic acid, Folic Acid, Sapropterin dihydrochloride, Thiamine, Vitamin B6 and B12 and Vitamin D. During the forecast period, the segment of carglumic acid will see significant growth. Carglumic acid is used to treat hyperammonemia in people with N-acetyl glutamate synthase deficiency. According to the United States Every year, approximately 30 newborns in the U.S. were diagnosed with hyperammonemia at national health institutes. Increasing hyperammonemia prevalence would fuel the market for carglumic acid over the duration of study.
Based on the Distribution Channel segment, the market is bifurcated into Hospital pharmacies, Retail pharmacies and online stores. The distribution channel group for hospital pharmacies will have a significant share over the coming years. Hospital pharmacies typically store a large number of drugs and advanced equipment and provide hospital patients with medication. The burden of genetic disorder would increase the number of hospitalizations, thereby having a positive effect on hospital pharmaceutical development.
The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. During the forecast period, North America is expected to lead the global market. Countries like Germany, the United States, Spain, and France are expected to deliver lucrative growth opportunities to players operating in this market. After North America, Europe is projected to be the second leading country. In addition, rising nutritional management activities in Asia Pacific provide this market with beneficial growth prospects.
Due to increased costs of amino acid supplements and patient non-compliance, the financial burden will decline the growth of the demand for amino acid metabolism disorder care in the coming years. It is estimated that the price in the UK is around € 4,000 per year. Additionally, lack of awareness of such disorders will negatively impact the growth of the market. The expansion of the industry will also have a negative impact on physiological stress, discomfort, inconvenience and risk of infections associated with frequent phenylketonuria injections.
Key players within global Amino Acid Metabolism Disorders Treatment market include AMINO GmbH, Civentichem, LLC, Koninklijke DSM N.V., Kyowa Hakko Kirin Co., Ltd, Merck KGaA and Recordati S.p.A. amongst others.
The report segments global Amino Acid Metabolism Disorders Treatment market as follows:
Global Amino Acid Metabolism Disorders Treatment Market: Indication Segment Analysis
Global Amino Acid Metabolism Disorders Treatment Market: Product Segment Analysis
Global Amino Acid Metabolism Disorders Treatment Market: Distribution Channel Segment Analysis
Global Amino Acid Metabolism Disorders Treatment Market: Regional Segment Analysis